Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials

AIMS/INTRODUCTION: The influence of overweight/obesity on the clinical efficacy and safety of sodium‐glucose co‐transporter 2 inhibitors is unclear. We carried out a pooled analysis to examine the impact of body mass index on the efficacy and safety of ipragliflozin. MATERIALS AND METHODS: Patient‐l...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Diabetes Investig
Auteurs principaux: Kashiwagi, Atsunori, Yoshida, Satoshi, Nakamura, Ichiro, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Satomi, Hayato, Kosakai, Yoshinori, Kawamuki, Kosei
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4931205/
https://ncbi.nlm.nih.gov/pubmed/27181576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12471
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires